U.S. Colorectal Cancer Screening Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (undefined)

U.S. Colorectal Cancer Screening Market is Segmented By Test Type (Fecal Immunochemical Test (FIT), Guaiac-based Fecal Occult Blood Test, Stool DNA Test, and Others), By Imaging Type (Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy, and Others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and Others). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of U.S. Colorectal Cancer Screening Market

Major Players operating in the U.S. colorectal cancer screening market include Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc., Olympus Corporation, Clinical Genomics Technologies Pty Ltd., Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Koninklijke Philips N.V., Thermo Fisher Scientific Inc., Illumina, Inc., Myriad Genetics Inc., QIAGEN, Merck KGaA

U.S. Colorectal Cancer Screening Market Leaders

  • Polymedco Inc.
  • Eiken Chemical Co. Ltd.
  • Sysmex Corporation
  • Quidel Corporation
  • Novigenix SA
*Disclaimer: Major players are listed in no particular order.

U.S. Colorectal Cancer Screening Market - Competitive Rivalry, 2023

Market Concentration Graph

U.S. Colorectal Cancer Screening Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights